Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
OMSAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2025 after the close of trading on Wednesday, February 11, 2026.
OneMain Financial Expands Commitment to Financial Education; Credit Worthy Curriculum Will Reach 2,000 High Schools Annually Through 2029
OMNEW YORK, Aug. 27, 2025 /PRNewswire/ -- OneMain Financial today announced an expansion of the company's financial education program, Credit Worthy by OneMain Financial, which will now reach students at an additional 500 high schools annually, targeting 2,000 schools each year through 2029....
Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference
OMSAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the 23rd annual Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 7 a.m. Eastern time.
Outset Medical Names Renee Gaeta as CFO, Effective Immediately
OMRBC Capital Maintains Sector Perform on Outset Medical, Raises Price Target to $21
OMRBC Capital Maintains Sector Perform on Outset Medical, Raises Price Target to $14
OMOutset Medical Affirms FY2025 Sales Guidance of $115.00M-$125.00M vs $120.30M Est
OMOutset Medical Q1 Adj. EPS $(3.24) Misses $(0.94) Estimate, Sales $29.75M Beat $27.81M Estimate
OMOutset Medical Announces 1-For-15 Reverse Stock Split
OMOutset Medical Sees FY2025 Sales $115.000M-$125.000M vs $121.32M Est
OMOutset Medical Q4 Adj $(0.37) Beats $(0.41) Estimate, Sales $29.47M Beat $28.47M Estimate
OMOutset Medical Notified By FDA That All Issues Cited In Jul. 2023 Warning Letter Have Been Addressed
OMOutset Medical Q3 2024 Adj. EPS $(0.39) Beats $(0.42) Estimate, Sales $28.666M Beat $26.905M Estimate
OMOutset Medical Raises FY2024 Sales Guidance from $110.00M to $112.00M
OMOutset Medical Narrow FY22 Sales Guidance From $142M-$150M To $144M-$150M vs $146.21M Est.
OMOutset Medical Q1 Adj. EPS $(0.67) Beats $(0.72) Estimate, Sales $30.60M Beat $30.11M Estimate
OM